Samuel Kintz

Companies

• Enliven Therapeutics, Inc.Board member Feb 27, 2023 to now¹
• Enliven Therapeutics, Inc.Chief executive officer Feb 27, 2023 to Dec 12, 2025¹
• Enliven Therapeutics, Inc.President Feb 27, 2023 to Dec 12, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN890,392 shares²$33.2M at $37.32Nov 17, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 17, 2025Sold 12,500 shares at $21.82 of Enliven Therapeutics, Inc.²
• Oct 17, 2025Sold 12,500 shares at $21.33 of Enliven Therapeutics, Inc.³
• Sep 26, 2025Sold 3,700 shares at $20.06 of Enliven Therapeutics, Inc.⁴
• Sep 23, 2025Sold 2,800 shares at $20.03 of Enliven Therapeutics, Inc.⁵
• Sep 19, 2025Sold 1,000 shares at $20.25 of Enliven Therapeutics, Inc.⁶
• Sep 17, 2025Sold 5,000 shares at $19.09 of Enliven Therapeutics, Inc.⁶
• Aug 20, 2025Sold 1,517 shares at $20.00 of Enliven Therapeutics, Inc.⁷
• Aug 19, 2025Sold 590 shares at $20.00 of Enliven Therapeutics, Inc.⁸
• Aug 18, 2025Sold 10,393 shares at $20.02 of Enliven Therapeutics, Inc.⁸
• Jul 17, 2025Sold 3,663 shares at $23.37 of Enliven Therapeutics, Inc.⁹
• Jul 17, 2025Sold 4,687 shares at $22.69 of Enliven Therapeutics, Inc.⁹
• Jul 17, 2025Sold 4,150 shares at $21.58 of Enliven Therapeutics, Inc.⁹
• Jun 17, 2025Sold 1,998 shares at $22.75 of Enliven Therapeutics, Inc.¹⁰
• Jun 17, 2025Sold 10,502 shares at $22.08 of Enliven Therapeutics, Inc.¹⁰
• Jun 3, 2025Sold 7,500 shares at $20.05 of Enliven Therapeutics, Inc.¹¹
• May 19, 2025Sold 5,000 shares at $16.49 of Enliven Therapeutics, Inc.¹²
• May 2, 2025Sold 2,170 shares at $20.00 of Enliven Therapeutics, Inc.¹³
• May 1, 2025Sold 5,330 shares at $20.08 of Enliven Therapeutics, Inc.¹³
• Apr 17, 2025Sold 5,000 shares at $16.42 of Enliven Therapeutics, Inc.¹⁴
• Mar 17, 2025Sold 12,500 shares at $20.83 of Enliven Therapeutics, Inc.¹⁵
• Oct 18, 2024Sold 924 shares at $30.00 of Enliven Therapeutics, Inc.¹⁶
• Oct 9, 2024Sold 2,830 shares at $28.53 of Enliven Therapeutics, Inc.¹⁷
• Oct 9, 2024Sold 13,880 shares at $28.07 of Enliven Therapeutics, Inc.¹⁷
• Oct 8, 2024Sold 100 shares at $28.51 of Enliven Therapeutics, Inc.¹⁷
• Oct 8, 2024Sold 13,167 shares at $27.95 of Enliven Therapeutics, Inc.¹⁷